| CAS Number | 70458-96-7 |
|---|---|
| Molecular Formula | C16H18FN3O3 |
| Molecular Weight | 319.33 |
| Pharmacopoeia | USP/BP/EP |
| Packaging | 25 KG/DRUM |
Norfloxacin Base is a fluoroquinolone antibiotic that serves as a broad-spectrum bactericidal agent. Its mechanism of action involves targeting and inhibiting bacterial DNA gyrase, a critical enzyme in DNA replication, transcription, and repair. This pharmaceutical-grade product meets the stringent requirements of USP, BP, and EP pharmacopoeia standards.
As a second-generation fluoroquinolone, Norfloxacin Base offers a balanced spectrum covering most Gram-negative organisms and select Gram-positive pathogens. Its favorable pharmacokinetic profile and well-documented safety record make it a reliable choice for diverse pharmaceutical dosage forms.
| Purity | As per USP/BP/EP monograph |
|---|---|
| Residual Solvents | Compliant with ICH Q3C |
| Heavy Metals | Compliant with pharmacopoeia limits |
| GMP Status | Manufactured under GMP conditions |
400mg strength for oral solid dosage forms targeting urinary tract infections and gastrointestinal bacterial infections.
0.3% eye drop formulations for bacterial conjunctivitis and superficial ocular infections.